|
ZNF569 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42694753183059E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76936243434511E-12 |
| Normal-vs-Stage2 |
2.50339999996463E-06 |
| Normal-vs-Stage3 |
1.22124532708767E-15 |
| Normal-vs-Stage4 |
2.44249065417534E-15 |
| Stage1-vs-Stage2 |
1.153890E-02 |
| Stage1-vs-Stage3 |
1.481440E-01 |
| Stage1-vs-Stage4 |
3.462700E-03 |
| Stage2-vs-Stage3 |
4.501800E-03 |
| Stage2-vs-Stage4 |
1.963540E-04 |
| Stage3-vs-Stage4 |
2.046200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99729122130066E-13 |
| Normal-vs-AfricanAmerican |
6.40530000040052E-07 |
| Normal-vs-Asian |
8.68405347631551E-12 |
| Caucasian-vs-AfricanAmerican |
6.719200E-01 |
| Caucasian-vs-Asian |
7.100400E-01 |
| AfricanAmerican-vs-Asian |
8.636600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.47912801398797E-13 |
| Normal-vs-Female |
2.1165291741454E-12 |
| Male-vs-Female |
4.833600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.07012185171607E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
8.22730772398472E-12 |
| Normal-vs-Age(81-100Yrs) |
2.356000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.293600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.508800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.672000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.861600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.948000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.356000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.357100E-04 |
| Classical-VS-Follicular |
1.176400E-03 |
| Classical-VS-Other |
9.023200E-01 |
| Classical-VS-Normal |
3.06288328033588E-12 |
| Tall-VS-Follicular |
1.70059999970995E-07 |
| Tall-VS-Other |
2.009000E-01 |
| Tall-VS-Normal |
1.62547753035369E-12 |
| Follicular-VS-Other |
3.877400E-01 |
| Follicular-VS-Normal |
1.91169999830265E-08 |
| Other-VS-Normal |
2.343700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-16 |
| Normal-vs-N1 |
2.22044604925031E-16 |
| N0-vs-N1 |
1.72294999999378E-05 |
|
|
